BenevolentAI Investor Conference Presentation Deck
9xchange Partnership
Benevolent X 9xc
Announced partnership 16 May 2023:
9xchange, is a biopharma marketplace created for innovators to match, buy and sell
drug assets
Marketplace and partnership promote information sharing and collaboration across the
biopharma industry to accelerate new drug discovery and development
BenevolentAl provides its Al technology to evaluate drug repurposability and
indication expansion in the 9xchange marketplace
ā
CEO & Founder Anat Naschitz also
co-founded and co-led OrbiMed
Israel, where she built companies
such as pharma spinout 89bio
(Nasdaq:ETNB)
The 9xchange marketplace is a curated,
members-only biopharma marketplace that
matches asset buyers and sellers and
removes friction by anonymising,
automating and enhancing many steps
required to get a deal done
BenevolentAl Proprietary
Benevolent 19View entire presentation